| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 25 |
| 1 | ACETAMINOPHEN | 15 |
| 2 | ETANERCEPT | 14 |
| 3 | MYCOPHENOLATE MOFETIL | 14 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 14 |
| 5 | INFLIXIMAB | 13 |
| 6 | ADALIMUMAB | 12 |
| 7 | INFLIXIMAB-DYYB | 11 |
| 8 | METHOTREXATE SODIUM | 11 |
| 9 | RITUXIMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAMLINTIDE ACETATE | 1 | 0.0098 |
| 1 | INFLIXIMAB-DYYB | 11 | 0.0032 |
| 2 | CLINDAMYCIN PHOSPHATE | 8 | 0.0014 |
| 3 | CHLORAMBUCIL | 5 | 0.0013 |
| 4 | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE | 1 | 0.0011 |
| 5 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 6 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 7 | IDELALISIB | 6 | 0.0009 |
| 8 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 9 | BRENSOCATIB | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 34 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 4 | Thalidomide Analog [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 12 |
| 6 | Kinase Inhibitor [EPC] | 11 |
| 7 | Proton Pump Inhibitor [EPC] | 11 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 6 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 8 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |